Top companies by COVID-19 treatment vaccines in development June 2022

Published by
Matej Mikulic,
Aug 29, 2023
As of June 3, 2022, there were 1,521 drugs and vaccines in development targeting the coronavirus disease (COVID-19). American biotech company Moderna was the second ranked company worldwide with 12 drugs/vaccines in development targeting COVID-19.

Leading companies by number of COVID-19 drugs and vaccines in development as of June 3, 2022

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

June 2022

Region

Worldwide

Survey time period

as of June 3, 2022

Open this statistic in...
Spanish
Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Coronavirus: the pharma and medtech response "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Coronavirus: the pharma and medtech response

Pharma - before the pandemic

6

Treatments and vaccines

8

Focus: BioNTech and Moderna

7

Opinions on COVID-19 vaccines

6

Business impact

4

Medtech - before the pandemic

5

Ventilators and testing

7

Further related statistics

16

Further Content: You might find this interesting as well

Statistics

Topics

Coronavirus disease (COVID-19) pandemicCoronavirus COVID-19 in ChinaCOVID-19: impact on the tourism industry worldwideCoronavirus (COVID-19) in the Asia-Pacific regionCoronavirus (COVID-19) in Italy
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu